• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Skip to investors navigation
Insmed

Insmed

Powered by Purpose

LinkedIn Twitter Contact Us Job Opportunities

  • Culture
    • Our Culture
      • Mission & Vision
      • Careers
      • Responsibility
        • Inclusion at Insmed
        • Grants & Funding
        • Global Healthcare Compliance

    Our Global Company

    Find available career opportunities in the U.S., Japan, or Europe.

    Find Jobs

  • Patients
    • Our Patients
      • Disease Areas
      • Resources
      • Patient Access

    Current Clinical Trials

    You may be eligible for one of our clinical trials.

    See if you may qualify

  • Science
    • Our Science
      • ARIKAYCE®
      • Our Research
      • Pipeline
      • Clinical Trials
      • Investigator-Initiated Research

    Our Research Team

    Working together to develop new medicines and technologies that have the potential to transform patients’ lives.

    Learn More

  • About
    • About Insmed
    • Management Team
    • Board of Directors
    • Partnerships
  • Investors
    • Investors
    • Events & Presentations
    • Stock Information
    • News Releases
    • SEC Filings
    • Annual Reports
    • Analyst Coverage
    • Corporate Governance
    • Email Alerts
    • Investor FAQs
Home / Investors/ News Releases

News Releases

Month Year
Su Mo Tu We Th Fr Sa
Month Year
Su Mo Tu We Th Fr Sa
Email Alerts
Advanced Search
  
Asset Types
           
 Basic Search
  • May 7, 2015
    Insmed Reports First Quarter 2015 Financial Results
  • Apr 6, 2015
    Insmed Announces Closing of Public Offering and Exercise of Option to Purchase Additional Shares
  • Mar 31, 2015
    Insmed Announces Pricing of Public Offering of Common Stock
  • Mar 30, 2015
    Insmed Announces Proposed Public Offering of Common Stock
  • Mar 27, 2015
    Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
  • Mar 23, 2015
    Insmed Appoints Dr. Eugene Sullivan as Chief Medical and Scientific Officer
    20 Year Industry Veteran Brings Industry, Clinical and Regulatory Experience in Pulmonary and Orphan Diseases
  • Feb 27, 2015
    Insmed Reports 2014 Fourth Quarter and Full Year Financial Results
    Marketing Authorization Application for ARIKAYCETM Validated by the European Medicines Agency
  • Feb 24, 2015
    Insmed to Participate at Cowen & Company's 35th Annual Health Care Conference
  • Jan 28, 2015
    Insmed to Participate at February Investment Conferences
  • Jan 13, 2015
    Insmed Incorporated Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
  • Jan 6, 2015
    Insmed to Present at the 33rd Annual J.P. Morgan Healthcare Conference
  • Dec 15, 2014
    Insmed Provides End of Year Regulatory and Clinical Update
  • Dec 15, 2014
    Insmed Appoints Myrtle Potter to its Board of Directors
    Pharmaceutical executive brings 30 years of commercial and operations leadership
  • Nov 26, 2014
    Insmed to Participate at December Investment Conferences
  • Nov 6, 2014
    Insmed Reports Third Quarter 2014 Financial Results
    Conference Call Begins Today at 8:30 a.m. Eastern Time
  • Sep 24, 2014
    Insmed to Participate in Leerink Partners' Rare Disease Roundtable
  • Sep 3, 2014
    Insmed Announces Multiple Clinical and Scientific Presentations at European Respiratory Society's International Congress 2014
  • Aug 18, 2014
    Insmed Announces Closing of Public Offering and Exercise of Option to Purchase Additional Shares
  • Aug 12, 2014
    Insmed Announces Pricing of Public Offering of Common Stock
  • Aug 6, 2014
    Insmed Reports Second Quarter 2014 Financial Results
  • Aug 4, 2014
    Insmed Provides Regulatory Update for ARIKAYCE
    Filing Marketing Authorization Application with European Medicines Agency for NTM Lung Disease and CF Indications
  • Jun 20, 2014
    Insmed to Present at the JMP Securities Healthcare Conference
  • May 29, 2014
    Insmed Appoints David R. Brennan to Its Board of Directors
  • May 20, 2014
    Insmed Announces Positive Open Label Data from Phase 2 Clinical Trial of ARIKAYCE for Treatment Resistant Nontuberculous Mycobacterial Lung Infections
    Poster Presentation at the American Thoracic Society Annual Meeting 2014
  • May 13, 2014
    Insmed Announces Data Presentations for ARIKAYCE in Two Orphan Lung Diseases at the American Thoracic Society Meeting
  • May 12, 2014
    Insmed to Participate in the Bank of America Merrill Lynch 2014 Health Care Conference
  • May 8, 2014
    Insmed Reports First Quarter 2014 Financial Results
  • Apr 7, 2014
    Insmed to Participate in the 13th Annual Needham & Co. Healthcare Conference
  • Apr 2, 2014
    Insmed Announces Leadership Team Transitions and Appointments to Expand Support for Growth Opportunities
  • Mar 26, 2014
    Insmed Announces Results from Phase 2 Clinical Trial for Treatment Resistant Nontuberculous Mycobacterial Lung Infections
    Conference Call with Insmed Management and Clinical Trial Investigators Will be Held Today at 8:00 a.m. Eastern Time
  • Mar 25, 2014
    Insmed to Announce Results From U.S. Phase 2 Clinical Trial for Treatment Resistant Nontuberculous Mycobacteria Lung Infections
  • Mar 6, 2014
    Insmed Reports 2013 Fourth Quarter and Full Year Financial Results
  • Feb 19, 2014
    Insmed Provides Interim Update from Two-Year, Open-Label Extension Study of ARIKACE to Treat Pseudomonas aeruginosa in Cystic Fibrosis Patients
    Initial 12-Month Data Demonstrate Long-Term Safety and Durability of Effect
  • Feb 10, 2014
    ARIKACE to Receive Orphan Medicinal Product Designation in the European Union to Treat Lung Infections Caused by Nontuberculous Mycobacteria
  • Feb 4, 2014
    Insmed to Present at the Leerink Swann Global Healthcare Conference
  • Feb 4, 2014
    Insmed to Present at the Leerink Swann Global Healthcare Conference
  • Nov 5, 2013
    Insmed Reports Third Quarter 2013 Financial Results
  • Nov 1, 2013
    Insmed Appoints David W.J. McGirr to Its Board of Directors
  • Oct 23, 2013
    Insmed to Host Third Quarter 2013 Financial Results Conference Call on Tuesday, November 5, 2013
  • Oct 15, 2013
    Insmed Completes Enrollment of Phase 2 Clinical Trial of ARIKACE to Treat Nontuberculous Mycobacteria Lung Disease in U.S. and Canada
  • Sep 15, 2013
    Insmed to Present at Leerink Swann Rare Disease Roundtable
  • Sep 11, 2013
    Insmed Fortifies Global Patent Portfolio
  • Sep 4, 2013
    Insmed to Participate in the Stifel Healthcare Conference 2013
  • Aug 7, 2013
    Insmed to Participate in August Investor Conferences
  • Aug 6, 2013
    Insmed Reports Second Quarter Financial Results
  • Jul 31, 2013
    Insmed to Host Second Quarter 2013 Financial Results Conference Call on Tuesday, August 6, 2013
  • Jul 29, 2013
    Insmed Appoints Christine Pellizzari as General Counsel and Corporate Secretary
  • Jul 22, 2013
    Insmed Announces Closing of Public Offering and Exercise of Option to Purchase Additional Shares
  • Jul 17, 2013
    Insmed Announces Pricing of Public Offering of Common Stock
  • Jul 15, 2013
    Insmed Announces Proposed Public Offering of Common Stock
Show 5102550100 per page
  • «
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 13
  • »
Stay In The Loop

Want to stay up to date on our news, events, and filings? Set up your
email alerts.

Sign Up

View the latest Insmed Investor Presentation

Download

Primary Sidebar

Investor Menu

  • Investors
  • Events & Presentations
  • Stock Information
  • News Releases
  • SEC Filings
  • Annual Reports
  • Analyst Coverage
  • Corporate Governance
  • Email Alerts
  • Investor FAQs

Investor Menu

Footer

Insmed
LinkedIn Twitter

Contact Us

Job Opportunities

  • Our Culture
    • Mission & Vision
    • Careers
    • Responsibility
      • Inclusion at Insmed
      • Grants & Funding
      • Global Healthcare Compliance
  • Our Patients
    • Disease Areas
    • Resources
    • Patient Access
  • Our Science
    • ARIKAYCE®
    • Our Research
    • Pipeline
    • Clinical Trials
    • Investigator-Initiated Research
  • About
    • Management Team
    • Board of Directors
    • Partnerships
  • Investors
  • Events & Presentations
  • Stock Information
  • News Releases
  • SEC Filings
  • Annual Reports
  • Analyst Coverage
  • Corporate Governance
  • Email Alerts
  • Investor FAQs

© 2023 Insmed Incorporated. All Rights Reserved. Terms of Use Privacy Policy

Culture
Patients
Science
logo
  • Culture
    • Mission & Vision
    • Careers
    • Responsibility
      • Inclusion at Insmed
      • Grants & Funding
      • Global Healthcare Compliance
  • Patients
    • Disease Areas
    • Resources
    • Patient Access
  • Science
    • ARIKAYCE®
    • Our Research
    • Pipeline
    • Clinical Trials
    • Investigator-Initiated Research
  • About
    • Management Team
    • Board of Directors
    • Partnerships
  • Investors
    • Investors
    • Events & Presentations
    • Stock Information
    • News Releases
    • SEC Filings
    • Annual Reports
    • Analyst Coverage
    • Corporate Governance
    • Email Alerts
    • Investor FAQs

LinkedIn Twitter

Contact Us Job Opportunities

© 2023 Insmed Incorporated.
All Rights Reserved.

Terms of Use Privacy Policy